Weighted Average Number of Shares Outstanding, Diluted of Aspira Women's Health Inc. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Aspira Women's Health Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2011 to Q3 2025.
  • Aspira Women's Health Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 36,388,370, a 136% increase year-over-year.
  • Aspira Women's Health Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 14,134,626, a 53% increase from 2023.
  • Aspira Women's Health Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 9,233,306, a 19% increase from 2022.
  • Aspira Women's Health Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 7,769,109, a 4.8% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Aspira Women's Health Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 36,388,370 +20,982,698 +136% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 35,564,032 +23,045,307 +184% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 21,590,573 +9,744,498 +82% 01 Jan 2025 31 Mar 2025 10-Q 19 May 2025 2025 Q1
Q4 2024 14,134,626 +4,901,320 +53% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 15,405,672 +5,629,236 +58% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 12,518,725 +4,118,568 +49% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 11,846,075 +3,532,984 +42% 01 Jan 2024 31 Mar 2024 10-Q 19 May 2025 2025 Q1
Q4 2023 9,233,306 +1,464,197 +19% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 9,776,436 +1,968,560 +25% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 8,400,157 +917,297 +12% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 8,313,091 +837,155 +11% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 7,769,109 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 7,807,876 -104,269,257 -93% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 7,482,860 -104,476,068 -93% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 7,475,936 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 112,077,133 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 111,958,928 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2

Aspira Women's Health Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 14,134,626 +4,901,320 +53% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 9,233,306 +1,464,197 +19% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 7,769,109 +355,068 +4.8% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 7,414,041 -93,309,262 -93% 01 Jan 2021 31 Dec 2021 10-K/A 26 Oct 2023 2022 FY
2020 100,723,303 +14,127,722 +16% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 86,595,581 +16,510,239 +24% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 70,085,342 +13,141,746 +23% 01 Jan 2018 31 Dec 2018 10-K 07 Apr 2020 2019 FY
2017 56,943,596 +4,745,627 +9.1% 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
2016 52,197,969 +5,073,708 +11% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
2015 47,124,261 +11,041,847 +31% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
2014 36,082,414 +15,156,078 +72% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 20,926,336 +5,915,468 +39% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 15,010,868 +761,298 +5.3% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
2011 14,249,570 01 Jan 2011 31 Dec 2011 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.